EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural Modification and Development of N -(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal Symptoms

Po-Wei Chang, Yung-Chiao Chang, Ya-Wen Tien, Hsiao-Fu Chang, Sheng-Ren Chen, Ya-Ping Chen, Wei-Cheng Huang, Chih-Chien Hsieh, Ling Chang, Hong Zhuang, Teng-Kuang Yeh, Chun-Wei Tung iD und 2 weitere

Journal of Medicinal Chemistry · 11.06.2026 · 69 (11) · 13222-13247

DOI: 10.1021/acs.jmedchem.6c00215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.06.2026. Verfasst von Po-Wei Chang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Benzamides, Analgesics, Opioid, Substance Withdrawal Syndrome, Isoquinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Research Institutes, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of N-(1,2,3,4-tetrahydro-3-isoquinolinylmethyl)benzamides, which are potent μ-opioid receptor (MOR) agonists, has been discovered. The most promising compound, compound 56 (BPR1M492), is an MOR agonist without a clear signaling bias between cAMP and β-arrestin-2 pathways, a cAMP-biased nociceptin-orphanin FQ opioid peptide agonist, and a weak cAMP-biased δ/κ-opioid receptor agonist. Compound 56 demonstrated potent in vivo antinociception at 0.027 mg/kg, offering rapid pain relief within 5 min of subcutaneous injection. It produced markedly milder withdrawal symptoms than TRV130 in mice, whereas differences in respiratory, gastrointestinal, reward-related, and tolerance-related measures were less pronounced and should be interpreted cautiously in light of the substantially lower dose required for antinociception. Compound 56 is a highly stable, slightly hygroscopic, low-moisture-containing crystalline solid that is safe at its in vivo effective dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzamidesAnalgesics, OpioidSubstance Withdrawal SyndromeIsoquinolinesAnimalsMiceReceptors, Opioid, muStructure-Activity RelationshipHumansMalePain

Substanzen

BenzamidesAnalgesics, OpioidReceptors, Opioid, muIsoquinolines

Autor:innen und Institutionen

  • Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli County 35053, Taiwan, R.O.C.
  • The Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan, ROC.
  • School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan, R.O.C.

ORCID-Profile: Chun-Wei Tung, Shiu-Hwa Yeh, Shau-Hua Ueng

Förderung

  • National Health Research Institutes
  • National Science and Technology Council

Zitieren

APA

Chang, P. W., Chang, Y. C., Tien, Y. W., Chang, H. F., Chen, S. R., Chen, Y. P., Huang, W. C., Hsieh, C. C., Chang, L., Zhuang, H., Yeh, T. K., Tung, C. W., Yeh, S. H., & Ueng, S. H. (2026). Structural Modification and Development of N -(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal Symptoms. Journal of Medicinal Chemistry, 69(11), 13222-13247. https://doi.org/10.1021/acs.jmedchem.6c00215

Vancouver

Chang PW, Chang YC, Tien YW, Chang HF, Chen SR, Chen YP, et al. Structural Modification and Development of N -(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal Symptoms. Journal of Medicinal Chemistry. 2026;69(11):13222-13247. doi:10.1021/acs.jmedchem.6c00215

BibTeX
@article{Chang2026,
  author = {Chang, Po-Wei and Chang, Yung-Chiao and Tien, Ya-Wen and Chang, Hsiao-Fu and Chen, Sheng-Ren and Chen, Ya-Ping and Huang, Wei-Cheng and Hsieh, Chih-Chien and Chang, Ling and Zhuang, Hong and Yeh, Teng-Kuang and Tung, Chun-Wei and Yeh, Shiu-Hwa and Ueng, Shau-Hua},
  title = {Structural Modification and Development of N -(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal Symptoms},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {11},
  pages = {13222--13247},
  doi = {10.1021/acs.jmedchem.6c00215}
}
Kostenlos starten →